CRISPR Therapeutics to Present at Upcoming Investor Conferences

On November 27, 2019 CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, reported that members of its senior management team are scheduled to make the following presentations in December (Press release, CRISPR Therapeutics, NOV 27, 2019, View Source [SID1234551759]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Evercore ISI 2nd Annual HealthCONx
Date: Wednesday, December 4, 2019
Presentation: 11:00 a.m. ET
Location: Boston, MA

Piper Jaffray 31st Annual Healthcare Conference
Date: Thursday, December 5, 2019
Presentation: 2:00 p.m. ET
Location: New York, NY

A live webcast of the events will be available on the "Events & Presentations" page in the Investors section of the Company’s website at View Source A replay of the webcast will be archived on the Company’s website for 30 days following the presentation.